Cargando…

Nf1 loss promotes Kras‐driven lung adenocarcinoma and results in Psat1‐mediated glutamate dependence

Mutations to KRAS are recurrent in lung adenocarcinomas (LUAD) and are daunting to treat due to the difficulties in KRAS oncoprotein inhibition. A possible resolution to this problem may lie with co‐mutations to other genes that also occur in KRAS‐driven LUAD that may provide alternative therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaojing, Min, Shengping, Liu, Hongli, Wu, Nan, Liu, Xincheng, Wang, Tao, Li, Wei, Shen, Yuanbing, Wang, Hongtao, Qian, Zhongqing, Xu, Huanbai, Zhao, Chengling, Chen, Yuqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554671/ https://www.ncbi.nlm.nih.gov/pubmed/31036704 http://dx.doi.org/10.15252/emmm.201809856

Ejemplares similares

The DEAD-box RNA helicase 51 controls non-small cell lung cancer proliferation by regulating cell cycle progression via multiple pathways
por: Wang, Xiaojing, et al.
Publicado: (2016)

Low-dose computed tomography (LDCT) versus other cancer screenings in early diagnosis of lung cancer: A meta-analysis
por: Wang, Xiaojing, et al.
Publicado: (2018)

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition
por: Liu, Hongli, et al.
Publicado: (2022)

The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p
por: Wei, Siliang, et al.
Publicado: (2019)

Hyperbaric Oxygen Therapy Represses the Warburg Effect and Epithelial–Mesenchymal Transition in Hypoxic NSCLC Cells via the HIF-1α/PFKP Axis
por: Zhang, Linling, et al.
Publicado: (2021)

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
por: Kostyrko, Kaja, et al.
Publicado: (2023)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
por: Ambrogio, Chiara, et al.
Publicado: (2016)

PSAT1 positively regulates the osteogenic lineage differentiation of periodontal ligament stem cells through the ATF4/PSAT1/Akt/GSK3β/β-catenin axis
por: Jia, Linglu, et al.
Publicado: (2023)

Stimulation of TLR4 by LMW-HA Induces Metastasis in Human Papillary Thyroid Carcinoma through CXCR7
por: Dang, Shipeng, et al.
Publicado: (2013)

Overexpression of PSAT1 regulated by G9A sustains cell proliferation in colorectal cancer
por: Wang, Huijuan, et al.
Publicado: (2020)

PPDPF Promotes the Development of Mutant KRAS‐Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1
por: Ni, Qian‐Zhi, et al.
Publicado: (2022)

PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells
por: Huang, Zhangsen, et al.
Publicado: (2021)

Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma
por: Wang, Min, et al.
Publicado: (2023)

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma
por: Wang, Yanxiao, et al.
Publicado: (2017)

Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
por: Wang, Jieqiong, et al.
Publicado: (2016)

Stabilization of Notch1 and β-catenin in response to ER- breast cancer-specific up-regulation of PSAT1 mediates distant metastasis
por: Zhu, Shuxuan, et al.
Publicado: (2022)

LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer
por: Wang, Ansheng, et al.
Publicado: (2019)

Iron out KRAS-driven cancer
por: Lei, Guang, et al.
Publicado: (2022)

Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors
por: Bhatt, Vrushank, et al.
Publicado: (2023)

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
por: Li, Kun, et al.
Publicado: (2022)

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis
por: Liao, Kuang-Ming, et al.
Publicado: (2016)

PSAT219 Renal Phosphate Wasting Caused by ENPP-1 mutation.
por: Madahar, Inderpreet, et al.
Publicado: (2022)

APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP
por: Gong, Huiyuan, et al.
Publicado: (2019)

MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways
por: Patel, Asmita, et al.
Publicado: (2014)

Corrigendum to “APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP” [EBioMedicine (2019)]
por: Gong, Huiyuan, et al.
Publicado: (2019)

Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma
por: Wang, Yuqiong, et al.
Publicado: (2021)

KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)

Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021)

PSAT185 Pseudohypoparathyroidism Type 1B: A Medication Compliance Challenge
por: Barreiro Sacco, Susana, et al.
Publicado: (2022)

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
por: Barbie, David A., et al.
Publicado: (2009)

Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth
por: Nagdas, Sarbajeet, et al.
Publicado: (2019)

Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo
por: Conroy, Lindsey R., et al.
Publicado: (2020)

Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
por: Pariollaud, Marie, et al.
Publicado: (2022)

Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model
por: Vannitamby, Amanda, et al.
Publicado: (2021)

Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer
por: Guo, Xiaoyu, et al.
Publicado: (2018)

The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer
por: Döppler, Heike, et al.
Publicado: (2016)

G6PD Maintains Redox Homeostasis and Biosynthesis in LKB1-Deficient KRAS-Driven Lung Cancer
por: Lan, Taijin, et al.
Publicado: (2023)

EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma
por: Xue, Liqiong, et al.
Publicado: (2019)

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy
por: Rosamaria, Pinto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pt6hqcjfa9trl444rrnula2c8u